In order to investigate the anticancer effect of Lycorine in prostate cancer, we determined its ability to inhibit NF-κB signaling activity using prostate cancer PC3 cells that stably express the NF-κB regulated luciferase reporter gene (PC3-NF-κB-Luc) 12. Here, NFKB1 is linked to prostate carcinoma.